Ranolazine following percutaneous coronary intervention: For whom? For what?

Expert Rev Cardiovasc Ther. 2016;14(5):541-3. doi: 10.1586/14779072.2016.1150176. Epub 2016 Feb 27.

Authors

Björn Redfors^{1

2}, Philippe Généreux^{1

3

4}

Affiliations

¹ a Cardiovascular Research Foundation , New York , NY , USA.
² b Sahlgrenska University Hospital , Gothenburg , Sweden.
³ c NewYork-Presbyterian/Columbia University Medical Center , New York , NY , USA.
⁴ d Hôpital du Sacré-Coeur de Montréal , Montréal , Québec , Canada.

PMID: 26840661
DOI: 10.1586/14779072.2016.1150176

No abstract available

Publication types

Editorial

MeSH terms

Angina Pectoris / therapy*
Humans
Percutaneous Coronary Intervention / methods*
Ranolazine / therapeutic use*

Substances

Ranolazine